These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 29932235)
1. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication. Huang CF; Wang SC; Yeh ML; Huang CI; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Chen A; Yu ML J Gastroenterol Hepatol; 2019 Jan; 34(1):249-255. PubMed ID: 29932235 [TBL] [Abstract][Full Text] [Related]
2. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment. Huang CF; Huang CY; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720 [TBL] [Abstract][Full Text] [Related]
3. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. Kumar V; Yi Lo PH; Sawai H; Kato N; Takahashi A; Deng Z; Urabe Y; Mbarek H; Tokunaga K; Tanaka Y; Sugiyama M; Mizokami M; Muroyama R; Tateishi R; Omata M; Koike K; Tanikawa C; Kamatani N; Kubo M; Nakamura Y; Matsuda K PLoS One; 2012; 7(9):e44743. PubMed ID: 23024757 [TBL] [Abstract][Full Text] [Related]
4. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis. Luo X; Wang Y; Shen A; Deng H; Ye M BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949 [TBL] [Abstract][Full Text] [Related]
5. Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C. Huang CF; Huang CI; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML Oncotarget; 2017 May; 8(20):32618-32625. PubMed ID: 28427234 [TBL] [Abstract][Full Text] [Related]
6. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample. Augello G; Balasus D; Fusilli C; Mazza T; Emma MR; Giannitrapani L; Agliastro R; Cervello M; Montalto G OMICS; 2018 Apr; 22(4):274-282. PubMed ID: 29584564 [TBL] [Abstract][Full Text] [Related]
7. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients. Marangon CG; de Bitencorte JT; Michita RT; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D Pathol Oncol Res; 2020 Jul; 26(3):1519-1525. PubMed ID: 31471884 [TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y; Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062 [TBL] [Abstract][Full Text] [Related]
9. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. Lange CM; Bibert S; Dufour JF; Cellerai C; Cerny A; Heim MH; Kaiser L; Malinverni R; Müllhaupt B; Negro F; Semela D; Moradpour D; Kutalik Z; Bochud PY; J Hepatol; 2013 Sep; 59(3):504-9. PubMed ID: 23665287 [TBL] [Abstract][Full Text] [Related]
10. The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients. Huang JF; Yeh ML; Yu ML; Dai CY; Huang CF; Huang CI; Tsai PC; Lin PC; Chen YL; Chang WT; Hou NJ; Lin ZY; Chen SC; Chuang WL J Gastroenterol Hepatol; 2015 Dec; 30(12):1768-74. PubMed ID: 26094738 [TBL] [Abstract][Full Text] [Related]
11. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. Calvaruso V; Cabibbo G; Cacciola I; Petta S; Madonia S; Bellia A; Tinè F; Distefano M; Licata A; Giannitrapani L; Prestileo T; Mazzola G; Di Rosolini MA; Larocca L; Bertino G; Digiacomo A; Benanti F; Guarneri L; Averna A; Iacobello C; Magro A; Scalisi I; Cartabellotta F; Savalli F; Barbara M; Davì A; Russello M; Scifo G; Squadrito G; Cammà C; Raimondo G; Craxì A; Di Marco V; Gastroenterology; 2018 Aug; 155(2):411-421.e4. PubMed ID: 29655836 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma. Hai H; Tamori A; Thuy LTT; Yoshida K; Hagihara A; Kawamura E; Uchida-Kobayashi S; Morikawa H; Enomoto M; Murakami Y; Kawada N Sci Rep; 2017 Sep; 7(1):11912. PubMed ID: 28928439 [TBL] [Abstract][Full Text] [Related]
13. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients. Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040 [TBL] [Abstract][Full Text] [Related]
14. Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance. Tong MJ; Theodoro CF; Salvo RT J Dig Dis; 2018 Jul; 19(7):411-420. PubMed ID: 29889353 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 28 Polymorphisms and Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy for Chronic Hepatitis C. Simili A; Mazzella G; Ravaioli F; Festi D; Bacchi-Reggiani ML; Porro A; Bazzoli F; Azzaroli F J Gastrointestin Liver Dis; 2019 Dec; 28(4):449-456. PubMed ID: 31826071 [TBL] [Abstract][Full Text] [Related]
17. Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response. Mücke VT; Thomas D; Mücke MM; Waidmann O; Zeuzem S; Sarrazin C; Pfeilschifter J; Vermehren J; Finkelmeier F; Grammatikos G Liver Int; 2019 Nov; 39(11):2174-2183. PubMed ID: 31207039 [TBL] [Abstract][Full Text] [Related]
18. Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication. Ohta A; Ogawa E; Murata M; Matsumoto Y; Yamasaki S; Ikezaki H; Furusyo N J Med Virol; 2022 Oct; 94(10):5007-5014. PubMed ID: 35652276 [TBL] [Abstract][Full Text] [Related]
19. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk. Lo PH; Urabe Y; Kumar V; Tanikawa C; Koike K; Kato N; Miki D; Chayama K; Kubo M; Nakamura Y; Matsuda K PLoS One; 2013; 8(4):e61279. PubMed ID: 23593449 [TBL] [Abstract][Full Text] [Related]
20. Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection. Huang CF; Wang SC; Chang WT; Yeh ML; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Chen YL; Yu ML Sci Rep; 2018 Oct; 8(1):15821. PubMed ID: 30361527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]